文献速递心境障碍焦虑、强迫与应激相关障碍物质与行为成瘾

21个国家精神与物质使用障碍的有效治疗情况

Effective Treatment for Mental and Substance Use Disorders in 21 Countries.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

这项横断面研究基于2001至2019年21国世界精神健康调查的56 927名成人数据,评估9种DSM-IV焦虑、心境和物质使用障碍的12个月有效治疗率。结果显示,有效治疗比例仅为6.9%(SE 0.3),主要障碍为低感知需求、有需求时低治疗接触以及获得最低充分治疗后低有效治疗。

要点

  • 12个月患病人次中接受有效治疗的比例为6.9%(SE 0.3)。
  • 低感知需求(46.5%;SE 0.6)是有效治疗的最大障碍。
  • 有感知需求时治疗接触低(34.1%;SE 1.0),获得最低充分治疗后有效治疗低(47.0%;SE 1.7)。

核心结论

  • 除治疗质量差距外,结果强调提高感知需求的重要性,感知需求是有效治疗的最大障碍。
  • 结果强调培训基层医疗临床医生识别和治疗精神障碍的重要性。
  • 结果强调改善照护连续性的需要,尤其是从最低充分治疗到有效治疗,并强调弥合男性和低教育人群有效治疗差距的重要性。

研究设计与样本

  • 横断面研究,在21个国家使用世界精神健康(WMH)调查,对代表性成人(18岁及以上)家庭样本进行调查。
  • 数据收集于2001年至2019年,分析于2024年2月至7月。
  • 使用复合国际诊断访谈评估9种DSM-IV焦虑、心境和物质使用障碍的12个月患病率和治疗。
  • 采用交叉表估计有效治疗及其组成部分,并使用多水平回归模型检验预测因素。
  • 共56 927名受访者(加权平均应答率69.3%),其中32 829名(57.7%)为女性;年龄中位数(IQR)为43(31-57)岁。

主要发现

  • 12个月患病人次中接受有效治疗的比例为6.9%(SE 0.3)。
  • 低感知需求为46.5%(SE 0.6),有感知需求时治疗接触为34.1%(SE 1.0),获得最低充分治疗后有效治疗为47.0%(SE 1.7)。
  • 国家层面一般医疗治疗资源比精神健康治疗资源更重要。
  • 除多变量障碍特征与所有中间结局相关外,其他显著预测因素在很大程度上被治疗接触所中介。

临床怎么用

  • 作者认为应提高感知需求,这是有效治疗的最大障碍。
  • 作者认为应培训基层医疗临床医生识别和治疗精神障碍。
  • 作者认为应改善照护连续性,尤其是从最低充分治疗到有效治疗。
  • 作者认为应弥合男性和低教育人群的有效治疗差距。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Accurate baseline information about the proportion of people with mental disorders who receive effective treatment is required to assess the success of treatment quality improvement initiatives. OBJECTIVE: To examine the proportion of mental and substance use disorders receiving guideline-consistent treatment in multiple countries. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, World Mental Health (WMH) surveys were administered to representative adult (aged 18 years and older) household samples in 21 countries. Data were collected between 2001 and 2019 and analyzed between February and July 2024. Twelve-month prevalence and treatment of 9 DSM-IV anxiety, mood, and substance use disorders were assessed with the Composite International Diagnostic Interview. Effective treatment and its components were estimated with cross-tabulations. Multilevel regression models were used to examine predictors. MAIN OUTCOMES AND MEASURES: The main outcome was proportion of effective treatment received, defined at the disorder level using information about disorder severity and published treatment guidelines regarding adequate medication type, control, and adherence and adequate psychotherapy frequency. Intermediate outcomes included perceived need for treatment, treatment contact separately in the presence and absence of perceived need, and minimally adequate treatment given contact. Individual-level predictors (multivariable disorder profile, sex, age, education, family income, marital status, employment status, and health insurance) and country-level predictors (treatment resources, health care spending, human development indicators, stigma, and discrimination) were traced through intervening outcomes. RESULTS: Among the 56 927 respondents (69.3% weighted average response rate), 32 829 (57.7%) were female; the median (IQR) age was 43 (31-57) years. The proportion of 12-month person-disorders receiving effective treatment was 6.9% (SE, 0.3). Low perceived need (46.5%; SE, 0.6), low treatment contact given perceived need (34.1%; SE, 1.0), and low effective treatment given minimally adequate treatment (47.0%; SE, 1.7) were the major barriers, but with substantial variation across disorders. Country-level general medical treatment resources were more important than mental health treatment resources. Other than for the multivariable disorder profile, which was associated with all intermediate outcomes, significant predictors were largely mediated by treatment contact. CONCLUSIONS AND RELEVANCE: In addition to the gaps in treatment quality, these results highlight the importance of increasing perceived need, the largest barrier to effective treatment; the importance of training primary care treatment clinicians in recognition and treatment of mental disorders; the need to improve the continuum of care, especially from minimally adequate to effective treatment; and the importance of bridging the effective treatment gap for men and people with lower education.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Vigo DV, Stein DJ, Harris MG, et al. Effective Treatment for Mental and Substance Use Disorders in 21 Countries. JAMA Psychiatry. 2025. PMID: 39908011. doi:10.1001/jamapsychiatry.2024.4378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。